Celldex Therapeutics
CLDX
CLDX
131 hedge funds and large institutions have $1.17B invested in Celldex Therapeutics in 2021 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 33 increasing their positions, 36 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1.83% more ownership
Funds ownership: 87.2% → 89.03% (+1.8%)
8% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 36
15% less call options, than puts
Call options by funds: $33.4M | Put options by funds: $39.5M
Holders
131
Holding in Top 10
5
Calls
$33.4M
Puts
$39.5M
Top Buyers
| 1 | +$57.9M | |
| 2 | +$24.8M | |
| 3 | +$10.7M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$10.2M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$7.91M |
Top Sellers
| 1 | -$20.2M | |
| 2 | -$17.5M | |
| 3 | -$12.6M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$10.8M |
| 5 |
Millennium Management
New York
|
-$10.4M |